TCM
ZOM

Traynor Capital Management’s Zomedica Corp. ZOM Stock Holding History

Traynor Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,104
Closed -$53K – 201
2021
Q1 		$53K Buy
+34,104
New +$55.7K 0.01% 173

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Traynor Capital Management's ZOM Position: Q2 2021 in Review

Traynor Capital Management sold out of Zomedica Corp. (ZOM) in Q2 2021, closing a stake of 34,104 shares — an estimated $53K sold.

Traynor Capital Management first reported a position in ZOM in Q1 2021 and held it in 1 quarter. The position peaked at $53K in Q1 2021. 106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

  • Traynor Capital Management reported no remaining Zomedica Corp. position as of Q2 2021 after selling out during the quarter.
  • Traynor Capital Management sold 34,104 Zomedica Corp. shares in Q2 2021, an estimated $53K.
  • Traynor Capital Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 1 quarter.
  • Traynor Capital Management's Zomedica Corp. position peaked at $53K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on Traynor Capital Management's 13F filing for Q2 2021, filed 21 Jul 2021.